These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 33058870)

  • 1. Domain Interactions Determine the Amyloidogenicity of Antibody Light Chain Mutants.
    Weber B; Hora M; Kazman P; Pradhan T; Rührnößl F; Reif B; Buchner J
    J Mol Biol; 2020 Nov; 432(23):6187-6199. PubMed ID: 33058870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mechanism of amyloidogenic mutations in hypervariable regions of antibody light chains.
    Rottenaicher GJ; Weber B; Rührnößl F; Kazman P; Absmeier RM; Hitzenberger M; Zacharias M; Buchner J
    J Biol Chem; 2021; 296():100334. PubMed ID: 33508322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased amyloidogenicity caused by mutational modulation of surface properties of the immunoglobulin light chain BRE variable domain.
    Kobayashi Y; Tsutsumi H; Abe T; Ikeda K; Tashiro Y; Unzai S; Kamikubo H; Kataoka M; Hiroaki H; Hamada D
    Biochemistry; 2014 Aug; 53(31):5162-73. PubMed ID: 25062800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fatal amyloid formation in a patient's antibody light chain is caused by a single point mutation.
    Kazman P; Vielberg MT; Pulido Cendales MD; Hunziger L; Weber B; Hegenbart U; Zacharias M; Köhler R; Schönland S; Groll M; Buchner J
    Elife; 2020 Mar; 9():. PubMed ID: 32151314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A constant domain mutation in a patient-derived antibody light chain reveals principles of AL amyloidosis.
    Rottenaicher GJ; Absmeier RM; Meier L; Zacharias M; Buchner J
    Commun Biol; 2023 Feb; 6(1):209. PubMed ID: 36823438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Antibody Light-Chain Linker Regulates Domain Orientation and Amyloidogenicity.
    Weber B; Hora M; Kazman P; Göbl C; Camilloni C; Reif B; Buchner J
    J Mol Biol; 2018 Dec; 430(24):4925-4940. PubMed ID: 30414962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Antibody Light-Chain Linker Is Important for Domain Stability and Amyloid Formation.
    Nokwe CN; Hora M; Zacharias M; Yagi H; John C; Reif B; Goto Y; Buchner J
    J Mol Biol; 2015 Nov; 427(22):3572-3586. PubMed ID: 26408269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the sequence features determining amyloidosis in human antibody light chains.
    Rawat P; Prabakaran R; Kumar S; Gromiha MM
    Sci Rep; 2021 Jul; 11(1):13785. PubMed ID: 34215782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protease-sensitive regions in amyloid light chains: what a common pattern of fragmentation across organs suggests about aggregation.
    Mazzini G; Ricagno S; Caminito S; Rognoni P; Milani P; Nuvolone M; Basset M; Foli A; Russo R; Merlini G; Palladini G; Lavatelli F
    FEBS J; 2022 Jan; 289(2):494-506. PubMed ID: 34482629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of domain interactions in the aggregation of full-length immunoglobulin light chains.
    Rennella E; Morgan GJ; Kelly JW; Kay LE
    Proc Natl Acad Sci U S A; 2019 Jan; 116(3):854-863. PubMed ID: 30598439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Stable Mutant Predisposes Antibody Domains to Amyloid Formation through Specific Non-Native Interactions.
    Nokwe CN; Hora M; Zacharias M; Yagi H; Peschek J; Reif B; Goto Y; Buchner J
    J Mol Biol; 2016 Mar; 428(6):1315-1332. PubMed ID: 26827727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential recruitment efficacy of patient-derived amyloidogenic and myeloma light chain proteins by synthetic fibrils-A metric for predicting amyloid propensity.
    Martin EB; Williams A; Wooliver C; Heidel RE; Adams S; Dunlap J; Ramirez-Alvarado M; Blancas-Mejia LM; Lands RH; Kennel SJ; Wall JS
    PLoS One; 2017; 12(3):e0174152. PubMed ID: 28350808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cryo-EM structure of cardiac amyloid fibrils from an immunoglobulin light chain AL amyloidosis patient.
    Swuec P; Lavatelli F; Tasaki M; Paissoni C; Rognoni P; Maritan M; Brambilla F; Milani P; Mauri P; Camilloni C; Palladini G; Merlini G; Ricagno S; Bolognesi M
    Nat Commun; 2019 Mar; 10(1):1269. PubMed ID: 30894521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects on light chain amyloid formation depend on mutations and type of glycosaminoglycans.
    Blancas-Mejía LM; Hammernik J; Marin-Argany M; Ramirez-Alvarado M
    J Biol Chem; 2015 Feb; 290(8):4953-4965. PubMed ID: 25538238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability and aggregation propensity do not fully account for the association of various germline variable domain gene segments with light chain amyloidosis.
    Garay Sánchez SA; Rodríguez Álvarez FJ; Zavala-Padilla G; Mejia-Cristobal LM; Cruz-Rangel A; Costas M; Fernández Velasco DA; Melendez-Zajgla J; Del Pozo-Yauner L
    Biol Chem; 2017 Apr; 398(4):477-489. PubMed ID: 27935845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Kinetic Stability of a Full-Length Antibody Light Chain Dimer Determines whether Endoproteolysis Can Release Amyloidogenic Variable Domains.
    Morgan GJ; Kelly JW
    J Mol Biol; 2016 Oct; 428(21):4280-4297. PubMed ID: 27569045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heat-induced native dimerization prevents amyloid formation by variable domain from immunoglobulin light-chain REI.
    Nawata M; Tsutsumi H; Kobayashi Y; Unzai S; Mine S; Nakamura T; Uegaki K; Kamikubo H; Kataoka M; Hamada D
    FEBS J; 2017 Sep; 284(18):3114-3127. PubMed ID: 28736891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations in specific structural regions of immunoglobulin light chains are associated with free light chain levels in patients with AL amyloidosis.
    Poshusta TL; Sikkink LA; Leung N; Clark RJ; Dispenzieri A; Ramirez-Alvarado M
    PLoS One; 2009; 4(4):e5169. PubMed ID: 19365555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in Protein Concentration Dependence for Nucleation and Elongation in Light Chain Amyloid Formation.
    Blancas-Mejía LM; Misra P; Ramirez-Alvarado M
    Biochemistry; 2017 Feb; 56(5):757-766. PubMed ID: 28074646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Gelsolin Pathogenic D187N Mutant Exhibits Altered Conformational Stability and Forms Amyloidogenic Oligomers.
    Srivastava A; Singh J; Singh Yadav SP; Arya P; Kalim F; Rose P; Ashish ; Kundu B
    Biochemistry; 2018 Apr; 57(16):2359-2372. PubMed ID: 29637772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.